Bicara Therapeutics Inc. ($BCAX)
Filing Information
| Accession Number | 0001628280-26-021543 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 26, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
16,500
Total Value
$125,073.30
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Mar 25, 2026 | Exercise/Conversion | 5,500 | $3.79 | $20,843.90 | 60,786 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 25, 2026 | Sale | 5,500 | $18.95 | $104,229.40 | 55,286 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Mar 25, 2026 | Exercise/Conversion | 5,500 | $0.00 | $0.00 | 47,413 | Direct | โ | View Details |